AP NEWS

Europe Basal Cell Carcinoma Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

December 5, 2018

DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The “Europe Basal Cell Carcinoma Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Basal Cell Carcinoma Market and Competitive Landscape - 2018, provides comprehensive insights into Basal Cell Carcinoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.This study accurately estimates and forecast Basal Cell Carcinoma market size and drug sales. This research also provides insights into Basal Cell Carcinoma epidemiology and late stage pipeline.

The research is classified into following sections - Basal Cell Carcinoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Basal Cell Carcinoma pipeline insights covering late stage clinical trials pipeline; Basal Cell Carcinoma prevalence trends by countries; Basal Cell Carcinoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Basal Cell Carcinoma: Disease Overview

2. Basal Cell Carcinoma Pipeline Insights

3. Basal Cell Carcinoma Epidemiology Analysis

4. Germany Basal Cell Carcinoma Market Insights

5. France Basal Cell Carcinoma Market Insights

6. Italy Basal Cell Carcinoma Market Insights

7. Spain Basal Cell Carcinoma Market Insights

8. UK Basal Cell Carcinoma Market Insights

9. Europe Basal Cell Carcinoma Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/dv7ftx/europe_basal_cell?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005357/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Skin Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 07:12 AM/DISC: 12/05/2018 07:12 AM

http://www.businesswire.com/news/home/20181205005357/en

AP RADIO
Update hourly